SDC for Lung Cancer Patients Treated With Curative Primary or Postoperative Radiotherapy or Chemoradiation
- Conditions
- Lung Cancer
- Registration Number
- NCT01855191
- Lead Sponsor
- Maastricht Radiation Oncology
- Brief Summary
Introducing standardized data collection (SDC) for lung cancer patients to improve the performance of the prediction models.
- Detailed Description
All patients planned for curative primary or postoperative radiotherapy can be included. Patients will be treated according to the institutional protocol. It is optional to collect a saliva sample for genetic profiling.
Follow up at five time points:
* 2 weeks after RT
* 3 months after RT
* 6 months after RT
* 12 months after RT
* 24 months after RT
At these time points, toxicity will be assessed. In addition, patients will receive a short questionnaire by mail at eight time points.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 864
- All patients planned for curatively intended radiotherapy or postoperative radiotherapy
- Recurrent disease
- All patients planned for palliative radiotherapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Two-year survival rate 24 months after RT
- Secondary Outcome Measures
Name Time Method Change in dysphagia During 24 months after RT Change in dyspnea during 24 months after RT Patient-rated generic quality of life During 24 months after RT Measured by Euroqol questionnaire
Change in cough During 24 months after RT
Trial Locations
- Locations (1)
MAASTRO clinic
🇳🇱Maastricht, Netherlands
MAASTRO clinic🇳🇱Maastricht, Netherlands